Drugs / Lifitgrast
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06624384 Comparator | Oct → Nov 2024 overdue | conjunctivitis | Mohsen Pourazizi | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lifitgrast | “The goal of this clinical trial is to compare the administration of 2 drugs, cyclosporine 0.05% (Restasis) and Lifitgrast (Xiidra) before PRK, in reducing the ocular surface...” NCT06624384 ↗ |
| Known as | Xiidra | “The goal of this clinical trial is to compare the administration of 2 drugs, cyclosporine 0.05% (Restasis) and Lifitgrast (Xiidra) before PRK, in reducing the ocular surface...” NCT06624384 ↗ |
| Route | Topical | “in the opposite eye, Lifitgrast eye drops are poured.” NCT06624384 ↗ |